Severance Hospital has marked another groundbreaking achievement by successfully operating on Mikhael Josepine Haresananda, a 7-year-old Indonesian boy born with a rare condition where his heart was outside his body.Haresananda was born with ectopia cordis, a mysterious ailment affecting 1 in 200,00
Celltrion Group Chairman Seo Jung-jin met with overseas investors and institutional stakeholders to present the blueprint for the group's merger and future vision.Seo attended the 21st Morgan Stanley Global Healthcare Conference in New York City, U.S., on Sep. 11 (local time), and shared the group's
An artificial intelligence-based prostate cancer diagnosis aid developed by a Korean company has received marketing authorization from overseas regulators, attracting the industry’s attention.Deep Bio said Tuesday that its AI-based prostate cancer diagnostic auxiliary software, DeepDx Prostate, rece
LifeSemantics said Tuesday it has decided to increase its capital by 20 billion won ($15 million) at its board of directors meeting.After shareholder allocation, the capital increase will be conducted as a public offering of forfeited shares. The first subscription will be for existing shareholders
SINGAPORE -- To enhance the competitiveness of new drug development, the Ministry of Food and Drug Safety (MFDS) needs to relax clinical trial regulations and create a standard of care reimbursement environment that meets global standards, an expert has suggested.Professor Lim Sun-min of the Lung Ca
VaxCell Biotherapeutics said it reported an impressive disease control rate (DCR) of “100 percent” for combination therapy using VAX-NK, its hepatocellular carcinoma (HCC) treatment candidate, and hepatic arterial infusion chemotherapy (HAIC), from its phase 2a trial.Speaking at a press conference a
It's been more than three years since gaming addiction became a "disease." There are still no treatments or systems in place. There are few attempts to deal with gaming addiction as a disease or gaming use disorder, and there is a lack of societal understanding. Instead, some criticize it as “pathol
Thomas Jefferson, the third president of the United States, experienced infrequent but intensely debilitating headaches, occurring perhaps once a decade. These headaches would persist for days, and in some cases, even weeks. The specific type of headache Jefferson endured remains unclear. While some
A recent study conducted by researchers at Yonsei University College of Medicine (YUCM) found that forcibly lowering blood pressure below 140mmHg in patients with acute ischemic stroke treated for endovascular thrombectomy (EVT) worsened prognosis by 1.84 times. High blood pressure, diabetes, and he
The Seoul Administrative Court has set a date for the verdict in the lawsuit between the Ministry of Food and Drug Safety (MFDS) and PharmaResearchBio regarding the latter's claims to cancel the MFDS' order to recall, destroy, and halt its botulinum toxin (BTX) product.The court will make the ruling
Access Bio said on Tuesday that it secured a new equity stake in CuraPatients, a U.S. digital population health-based company, to accelerate its entry into the American digital healthcare sector.Access Bio is a Kosdaq-listed U.S. company developing next-generation diagnostic kits in which Korean pha
Kolmar Korea Corp. said it has emerged victorious in a trade secret infringement lawsuit against the Korean subsidiary of the Italian cosmetics company, Intercos.The Seoul Central District Court ruled in favor of Kolmar Korea in the lawsuit against Intercos Korea and some former researchers for brea
Samsung Bioepis said it has entered into a commercialization agreement with Sandoz for SB17, a proposed biosimilar for Stelara (ingredient: ustekinumab), for North America and Europe.Stelara was developed by multinational pharmaceutical company Janssen, the pharmaceutical arm of Johnson & Johnson (J
In a recent development regarding corporate trade secrets, Samsung Biologics has achieved a partial victory in its lawsuit against three former employees who moved to Lotte Biologics. The company accused the former employees of breaching trade secrets.According to Money Today, a local news outlet, t
The international journal Nature has compiled the performance of countries, universities, and companies in anticancer research worldwide, but Korea did not even make the list.According to the Bioeconomy Research Center of the Korea BIO, an industry association, Nature released the results of the sha
Lunit's artificial intelligence (AI) diagnostic assistant solution draws the industry's attention by being used for the final breast cancer diagnosis in Europe.Industry executives are watching with interest whether Lunit's AI solution can become part of the screening system in Europe, where there is
HK inno.N has partnered with Dong-A ST to develop a next-generation non-small cell lung cancer (NSCLC) treatment. The company announced its ambition to develop a fifth-generation NSCLC treatment through protein degradation, going beyond epithelial growth factor receptor (EGFR) inhibitors.HK inno.N s
The Ministry of Trade Industry and Energy said on Monday that the Korean Agency for Technology and Standards (KATS) division’s new proposal (NP) for the brain-computer interface (BCI) data format was approved at the BCI International Standardization Organization (ISO/IECJTC1SC43) plenary meeting hel
SINGAPORE -- Dr. Ahn Myung-ju, professor of hematology and oncology at Samsung Medical Center, received the Adi F. Gazdar IASLC Distinguished Service Award at the International Association for the Study of Lung Cancer (IASLC) World Conference on Lung Cancer 2023 (WCLC 2023) in Singapore on Sunday.Th
Yonsei Cancer Center's Lung Cancer Center team has earned the prestigious title of Asia's best multidisciplinary team during the World Conference on Lung Cancer 2023 (WCLC 2023), held in Singapore from last Saturday to Tuesday. This achievement marks a significant milestone, as it is the first time